Search Results - "Meggitt, S.J."

British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011 by Meggitt, S.J., Anstey, A.V., Mohd Mustapa, M.F., Reynolds, N.J., Wakelin, S.

Get full text

Measuring disease activity and damage in discoid lupus erythematosus by Wahie, S., McColl, E., Reynolds, N.J., Meggitt, S.J.

“…Summary Background  Discoid lupus erythematosus (DLE) is a disfiguring inflammatory skin disease. There is no specific tool for measuring disease severity…”
Get full text

Long-term response to hydroxychloroquine in patients with discoid lupus erythematosus by Wahie, S., Meggitt, S.J.

“…Summary Background The recommended first‐line oral therapy for discoid lupus erythematosus (DLE) is the antimalarial hydroxychloroquine. To the best of our…”
Get full text

Mepacrine‐induced interstitial lung disease in discoid lupus erythematosus? by Waas, R.L.V., Meggitt, S.J.

Get full text

An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema by Weatherhead, S.C., Wahie, S., Reynolds, N.J., Meggitt, S.J.

“…Summary Background  Treatment options for moderate‐to‐severe atopic eczema are limited. Although methotrexate (MTX) is a widely used and effective treatment…”
Get full text

Translating translation into patient benefit for atopic eczema by Reynolds, N.J., Sinha, A., Elias, M.S., Meggitt, S.J.

“…Summary This review considers, in the context of British Skin Foundation (BSF)‐funded translational research into atopic eczema conducted in Newcastle, the…”
Get full text

Mutilating male genital Crohn's without gastrointestinal involvement by Winn, R.T., Brass, D., Meggitt, S.J.

Get full text

Measuring disease activity and damage in cutaneous lupus erythematosus: Correspondence by Wahie, S., Mc Coll, E., Reynolds, N.J., Meggitt, S.J.

Get full text

Measuring disease activity and damage in discoid lupus erythematosus: Measuring disease severity in DLE by Wahie, S., McColl, E., Reynolds, N.J., Meggitt, S.J.

Get full text

Raised limb bands developing in infancy: Correspondence by Lateo, S.A., Taylor, A.E.M., Meggitt, S.J.

Get full text

Measuring disease activity and damage in cutaneous lupus erythematosus by Wahie, S., Mc Coll, E., Reynolds, N.J., Meggitt, S.J.

Get full text

Elevated Expression and Genetic Association Links the SOCS3 Gene to Atopic Dermatitis by Ekelund, E., Sääf, A., Tengvall-Linder, M., Melen, E., Link, J., Barker, J., Reynolds, N.J., Meggitt, S.J., Kere, J., Wahlgren, C.-F., Pershagen, G., Wickman, M., Nordenskjöld, M., Kockum, I., Bradley, M.

“…In a systematic analysis of global gene-expression patterns, we found that SOCS3 messenger RNA was significantly more highly expressed in skin from patients…”
Get full text

Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation: Correspondence by Wahie, S., Alexandroff, A., Reynolds, N.J., Meggitt, S.J.

Get full text

Raised limb bands developing in infancy by Lateo, S.A., Taylor, A.E.M., Meggitt, S.J.

Get full text

Myotoxicity occurring with ciclosporin in a patient with atopic dermatitis by Wahie, S., Meggitt, S.J.

Get full text

Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation by Wahie, S., Alexandroff, A., Reynolds, N.J., Meggitt, S.J.

Get full text

Raised limb bands developing in infancy by Meggitt, S.J., Harper, J., Lacour, M., Taylor, A.E.M.

“…Summary Congenital cutaneous constriction bands are rare and often occur with other abnormalities, including the presence of rudimentary digits. This diverse…”
Get full text

Raised limb bands developing in infancy by Meggitt, S.J., Harper, J., Lacour, M., Taylor, A.E.M.

Get full text